-
Here's Why Pfizer's a Great Stock to Buy and Hold Now
Post on 2/5/21
-
What's Behind Merck's Disappointing Q4 Results?
Post on 2/5/21
-
Northern Westchester Hospital Opens State-of-the-art Electrophysiology Lab
Post on 2/4/21
-
Quest Diagnostics Reports Fourth Quarter And Full Year 2020 Financial Results
Post on 2/4/21
-
AmerisourceBergen Reports Fiscal 2021 First Quarter Results
Post on 2/4/21
-
TYME Provides Business Update and Announces Third Quarter Fiscal 2021 Financial and Operating Results
Post on 2/4/21
-
Merck Announces Fourth-Quarter and Full-Year 2020 Financial Results
Post on 2/4/21
-
TYME Announces $100 Million Registered Direct Offering of Common Stock
Post on 2/4/21
-
Is It Too Late to Buy Pfizer Stock?
Post on 2/4/21
-
Why Pfizer's Q4 Results Simply Don't Matter Very Much
Post on 2/3/21
-
Outlook Therapeutics Closes of $35.0 Million Public Offering of Common Stock
Post on 2/3/21
-
Neuronetics Announces Closing of Public Offering
Post on 2/3/21
-
Krystal Biotech Announces Prices of Upsized $125 Million Public Offering of Common Stock
Post on 2/3/21
-
Geisinger and Children's Hospital of Philadelphia Announce Affiliation Agreement
Post on 2/2/21
-
Krystal Biotech Proposes $100M Public Offering of Common Stock
Post on 2/2/21
-
Helius Medical Technologies Closes $11.0M Underwritten Public Offering
Post on 2/1/21
-
Quest Diagnostics Named One of 2021 "World's Most Admired Companies" by FORTUNE Magazine for Seventh Consecutive Year
Post on 2/1/21
-
ADMA Biologics Receives FDA Approval for ADMA BioCenters Plasma Collection Facility in Knoxville, TN
Post on 2/1/21
-
Look Out, Pfizer and Moderna: Here Comes Novavax
Post on 2/1/21
-
Better Coronavirus Stock: Johnson & Johnson vs. Pfizer
Post on 2/1/21
-
Can Moderna and Pfizer Meet President Biden's Vaccine Goals?
Post on 2/1/21
-
Johnson & Johnson Says Its One-Dose Coronavirus Vaccine Was 66% Effective in Clinical Trial
Post on 2/1/21
-
Which Is the Best COVID Vaccine Stock: Pfizer, BioNTech, Moderna, Johnson & Johnson, or Novavax?
Post on 2/1/21
-
VYNE Therapeutics Closes of $50 Million Registered Direct Offering of Common Stock
Post on 1/29/21
-
Better Buy: Pfizer vs. BioNTech
Post on 1/29/21
Philadelphia
